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Abstract
Background: Cytochrome P450 monooxygenases (CYPs) form a vast and diverse family of highly variable
sequences. They catalyze a wide variety of oxidative reactions and are therefore of great relevance in drug
development and biotechnological applications. Despite their differences in sequence and substrate specificity, the
structures of CYPs are highly similar. Although being in research focus for years, factors mediating selectivity and
activity remain vague.
Description: This systematic comparison of CYPs based on the Cytochrome P450 Engineering Database (CYPED)
involved sequence and structure analysis of more than 8000 sequences. 31 structures have been applied to
generate a reliable structure-based HMM profile in order to predict structurally conserved regions. Therefore, it was
possible to automatically transfer these modules on CYP sequences without any secondary structure information,
to analyze substrate interacting residues and to compare interaction sites with redox partners.
Conclusions: Functionally relevant structural sites of CYPs were predicted. Regions involved in substrate binding
were analyzed in all sequences among the CYPED. For all CYPs that require a reductase, two reductase interaction
sites were identified and classified according to their length. The newly gained insights promise an improvement
of engineered enzyme properties for potential biotechnological application. The annotated sequences are
accessible on the current version of the CYPED. The prediction tool can be applied to any CYP sequence via the
web interface at http://www.cyped.uni-stuttgart.de/cgi-bin/strpred/dosecpred.pl.
Background
Cytochrome P450 monooxygenases (CYPs) are a ubiqui-
tous protein family, existing in all eukaryotes, most pro-
karyotes and Archae. These heme-containing enzymes
catalyze the monooxygenation of a large variety of sub-
strates [1]. CYPs have an essential function in drug meta-
bolism, hence focussed in the pharmaceutical industry
[2]. Besides, they are of great interest for synthetical
application in biotechnology as versatile biocatalysts [3].
A profound knowledge in the factors mediating selectiv-
ity and activity of these proteins is a prerequisite in the
development of CYPs with improved properties. There-
fore, deeper insights in the relationships between
sequence, structure and function are of great interest.
According to Nelson’sc l a s s i f i c a t i o n[ 4 ]C Y P sa r e
grouped into homologous families and superfamilies, pre-
dominantly based on sequence similarity. The sequence
identity between proteins from different superfamilies is
extremely low and may be less than 20% [5]. Only three
amino acids are totally conserved, the glutamic acid and
the arginine of the ExxR-motif, which is involved in stabi-
lizing the core and heme-binding [6], and the heme-bind-
ing cysteine. However, the increasing number of crystal
structures shows that despite this unusual variability the
overall structure is highly conserved: CYPs consists of
structural conserved modules that are essential for struc-
ture and function, and of variable regions that mediate
the individual biochemical properties. The defined con-
served secondary structures are named aA-L and b1-5
and could be identified in all CYP structures and make
up the so called CYP-fold [7-9].
Most CYPs require interaction with a reductase to pro-
vide electrons, either as separate proteins or as fusion
proteins. Depending on the nature of their electron
transfer partner, CYPs are assigned to different classes.
Although, no consensus has been reached in the defini-
tion of this classification, there are several proposed
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[10-12]. The most general one, which was applied in this
work, discriminates between two major classes of CYPs
[13]: class I, which comprises mitochondrial and bacterial
CYPs and class II which comprises CYPs interacting with
a cytochrome P450 reductase-type (CPR-type) FMN/
FAD reductase and represents a simplification of the
widely accepted classification scheme by Kelly et al. in
[1]. Further, there are CYPs known which do not need a
reductase for their reaction [14]. Fusion proteins, such as
the self-sufficient class II CYP 102A1 from Bacillus
megaterium (P450 BM-3) which contains a heme domain
and a reductase, as well as those CYPs which do not
require any reductase interaction appear very rarely in
nature [15]. Therefore, in most CYPs the interaction with
their appropriate redox partner is prerequisite for their
reaction to occur. Many different CYP isoenzymes inter-
act with only one reductase, and it is assumed that CYPs
of the same class are comparable in regard to their reduc-
t a s ei n t e r a c t i o ns i t e s[ 1 6 ] .I ti se x p e c t e dt h a tt h e r ea r e
favorable electrostatic interactions between CYPs and
their electron transfer partner [17]. A crystal structure
for a CYP-reductase-complex is not yet available. Even
though the kinetics in P450 reduction may not be gener-
alized among different P450 systems, and the concepts
regarding the influence of a rate-limiting step are not
universal [18], the electron transfer from the reductase to
the heme domain is often slow and one of the rate-limit-
ing aspects in many CYP systems [19]. However, the
interactions between the components of the electron
transfer systems still remain unclear. A deeper under-
standing of the factors determining reductase interaction
gained by the analysis of the reductase interaction sites of
CYPs will assist in improving interactions and conse-
quently lead to optimized enzymes for biocatalytic appli-
cations [20].
Previous analyses of the structure conservation in
CYPs showed that all CYPs have a well-conserved
heme-binding structural core formed out of aD, aE, aI,
and aLa n daJa n daK [21]. The b-bulge region which
contains the thiolate heme ligand is referred to as Cys-
pocket. Between aK and the Cys-pocket, a structurally
conserved region is located, the so-called ‘meander’
loop. It is spanned by 7-10 amino acid residues and is
supposed to play a role in heme binding and stabiliza-
tion of the tertiary structure. The proposed reductase
interaction face of CYPs mainly comprises the aJ/aJ’
and the insertion following the meander loop [6]. Since
the structures of all CYPs are highly similar, but differ
in substrate specificity and their electron transfer part-
ners, the different biochemical properties of CYPs are
mediated by the diverse regions, which vary in both
sequence and structure [8].
Six regions which are involved in recognition and bind-
ing of substrates and hence determine substrate specifi-
city were described as SRSs (substrate recognition sites
[22]). SRS1 lies in the highly variable loop region between
aBa n daC (BC-loop), SRS2 is located in the C-terminal
end of aF, SRS3 and SRS4 are spanned by the N-terminal
regions of aGa n daI, b1-4 houses SRS5 and b4-1 SRS6.
While the access of the substrate to the binding pocket is
limited by flexible regions in the entrance channel, such
as aFa n daG which undergo strong conformational
changes upon substrate binding [23,24], the regions
flanking directly the binding pocket and thus limiting the
access of the substrate to the heme, namely aI, the
BC-loop region and SRS5, were observed to remain rigid
during simulation [25,26]. In a systematic analysis of
SRS5 in more than 6300 sequences, single substrate- and
heme-interacting residues could be identified in this
region [27]: Thus, a hotspot for regio- and stereoselectiv-
ity in one residue in SRS5 and one position in the
BC-loop (F87), were previously reported as key residues
in determining activity, regio- and stereoselectivity in
CYP102A1 [28-30]. Combinations of variants of these
two positions were applied to design a minimal mutant
library with improved selectivity [31]. Due to the high
variability of the BC-loop, the identification of position
87 in CYP102A1 in other CYPs, remains a challenge for
sequences without structural information.
To serve as a tool for a comprehensive comparison of
protein sequences and structures within the vast and
diverse family of CYPs in order to transfer the newly
gained insights among the CYP sequences, the Cyto-
chrome P450 Engineering Database (CYPED)[ 3 2 ]h a s
been designed. In its current version 2.02 it contains
8614 sequences [33]. The highly similar structures have
been compared in detail to identify the common core
a n dt oa s s i g nt h ev a r i a b l er e g i o n s .F o rt h i sp u r p o s ea
structural alignment was used as a base to generate a reli-
able structure profile. With this profile all structurally
conserved regions (SCR) could be predicted and anno-
tated among all CYPED protein sequence entries, hence
allowing a structural navigation in those sequences lack-
ing structural information. Beyond this, the CYPED web-
site provides an interface which allows the prediction of
the SCRs for every user-specified CYP sequence.
Data
CYP Structures
A set of 31 PDB structures [34] was extracted from ver-
sion 1.1 of the CYPED [32] as listed in table 1. The
selection includes 16 bacterial structures of class I and
12 CYPs assigned to class II CYPs, comprising CYPs
which interact with a CPR-type FMN/FAD reductase.
The structures in this class are predominantly of
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(P450 BM-3) from Bacillus megaterium,w h i c hi sa
fusion enzyme, consisting of a P450 domain and a
FMN/FAD reductase domain [15]. Because of its struc-
tural similarity to CYP102A1, the bacterial CYP175A1
isolated from the thermophilic Thermus thermophilus
was also assigned to class II [14]. Additionally analyzed
crystal structures were: CYP8A (human prostacyclin
synthase), which accepts endoperoxides or hydroperox-
ides as substrates and does not require any electron-
transfer partner or molecular oxygen [35]; CYP55A2
from Fusarium oxisporum and 152A1 from Bacillus
subtilis (P450Bsb) are representatives for CYPs which
obtain electrons directly from NAD(P)H or catalyze a
peroxide-dependent reaction. All structures represent
the closed form of CYPs since including the open form
as available for example for CYP2B4 [36] would worsen
the alignment quality. Eleven recently published CYP
structures were not included in the alignment but were
used to validate the prediction of the structurally con-
served regions.
CYP Sequences
The analysis of CYP sequences and structures was
performed based on the updated version 2.02 of the
CYPED [33]. It integrates sequences of 8614 proteins.
The proteins are organized into 249 superfamilies and
619 homologous families according to Nelson [4]. Reli-
able multisequence alignments are available for each
family. The sequences are annotated by automatically
extracted GenBank annotations [37], which were manu-
ally enriched. Secondary structure information is avail-
able as DSSP annotation within the multisequence
alignments for those homologous families containing
members with existing PDB structures.
Methods
Structure-based HMM profile
SCRs were determined by the generation of a structure-
based multisequence alignment using STAMP [38].
STAMP estimates the probability of structural equiva-
lence of residues [39] and uses the Smith-Waterman
algorithm [40] to determine the best path through a
matrix of numerical pairwise similarity values of corre-
sponding sequence positions. This allows STAMP to
calculate two measures of alignment confidence: P’ij,a
measure for residue equivalence and Sc,t h eS T A M P
score, which reflects overall alignment quality. A Sc >
5.5 implies a high degree of similarity of the considered
structures. Stretches of residues in the alignment having
P’ij > 6.0 imply regions of conserved secondary structure
and are marked by black boxes in the alignment output.
To visualize secondary structure information on the
alignment output, STAMP uses DSSP [41] outputs.
Therefore, in a first step DSSP was applied on the CYP
structures to calculate secondary structure information.
The resulting structure-based multisequence alignment
was checked for correctly aligned secondary structures,
ExxR motif and Cys-pocket. Regions with high P’ij
which indicate conserved secondary structures were
defined as SCR, extracted from the alignment and visua-
lized (Figure 1) on the structure from CYP102A1 [PDB:
1BU7] as reference structure using PyMOL [42]. Struc-
ture-based HMM-profiles were derived from the struc-
ture-based multisequence alignments using HMMER
http://hmmer.janelia.org/.
Table 1 List of CYP structures analyzed in this work
CYP PDB entry Resolution [Å] Ligand Organism
Class II CYPs (CPR-type)
1A2 2HI4 1.95 + Homo sapiens
2A6 1Z10 1.90 + Homo sapiens
2A13 2P85 2.35 + Homo sapiens
2B4 1SUO 1.90 + Oryctolagus cuniculus
2C5 1N6B 2.30 + Oryctolagus cuniculus
2C8 1PQ2 2.70 + Homo sapiens
2C9 1OG2 2.60 + Homo sapiens
2D6 2F9Q 3.00 - Homo sapiens
2R1 2OJD 2.80 + Homo sapiens
3A4 1TQN 2.05 - Homo sapiens
102A1 1BU7 1.65 - Bacillus megaterium (P450
BM-3)
175A1 1N97 1.80 - Thermus thermophilus
Class I CYPs
51B1 1E9X 2.10 + Mycobacterium tuberculosis
101D 2CPP 1.63 + Pseudomonas putida
(P450cam)
107A1 1OXA 2.10 + Saccharopolyspora erythrea
107L1 2BVJ 2.10 - Streptomyces venezuelae
108A 1CPT 2.30 - Pseudomonas sp.
119 1IO7 1.50 - Sulfolobus solfactaricus
154A1 1ODO 1.85 + Streptomyces coelicolor
154C1 1GWI 1.92 - Streptomyces coelicolor
158A1 2DKK 1.97 + Streptomyces coelicolor
158A2 1S1F 1.50 + Streptomyces coelicolor
165B3 1LFK 1.70 - Amicolatopsis orientalis
165C4 1UED 1.90 - Amicolatopsis orientalis
167A1 1Q5D 1.93 + Polyangium cellulosum
176A1 1T2B 1.70 + Citrobacter brakii
199A2 2FR7 2.01 - Rhodopseudomonas
palustris
245A1 2Z3T 1.90 + Streptomyces sp. TP-A0274
Other CYPs
8A 2IAG 2.15 - Homo sapiens
55A2 1CL6 1.70 + Fusarium oxisporum (NO
reductase)
152A1 1IZO 2.10 + Bacillus subtilis (P450Bsb)
Ligand-free and ligand-bound structures are indicated by - and +, respectively.
Sirim et al. BMC Structural Biology 2010, 10:34
http://www.biomedcentral.com/1472-6807/10/34
Page 3 of 12Structural analysis
Structural superpositions and visualizations were gener-
ated using PyMOL [42]. The analysis of the BC-loop
region was performed by an overall superposition of all
structures on CYP102A1 [PDB: 1BU7]. The visualization
of the reductase interaction sites RIS1 and RIS2 was
generated by the superposition of the FMN-domains of
CYP102A1 [PDB: 1BVY] and the CPR-type FMN/FAD
reductase from Rattus norvegicus [PDB: 3ES9] and the
superposition of the P450-domains of CYP2C9 from
Homo sapiens [PDB: 1OG2] CYP101D and from Pseudo-
monas putida [PDB: 2CPP] on the P450-domain of
CYP102A1.
Sequence analysis
For the analysis of all CYP sequences, the CYPED and the
DWARF system [43] were applied. The data warehouse
system DWARF is the in-house repository for the CYPED
data and assists local analysis. Besides integrating
sequences and structures of this protein family, it pro-
vides a set of bioinformatics tools for sequence and struc-
ture analysis. We took advantage of its modular and
extensible architecture and designed a Perl program
which implements an automated procedure that subse-
quently generates a structure-based multisequence align-
ment for every CYPED e n t r yb ym a p p i n gi to nt h e
structure-based HMM profile which was derived from
the STAMP alignment. Using the alignment row which
represents the structure of CYP102A1 as a reference, the
start and stop positions of each conserved secondary
structure were identified within each alignment and
transferred to the query sequence. Therefore, the abso-
lute positions of the SCRs of each query sequence could
be predicted. The positions were stored as annotations in
the CYPED and are visualized in the multisequence align-
ments and on the feature page for each CYPED entry.
The same procedure as for the identification of the SCRs
was applied to identify the specificity and regioselectivity
F.igure 1 SCRs of CYPs in a structural overview. The structurally conserved regions were derived from the STAMP alignment and mapped on
the reference structure of P450 BM-3 from Bacillus megaterium [PDB: 1BU7]. The SCRs are highlighted in blue, whereas the variable regions are
shown in green.
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CYP102A1 in all sequences among the CYPED. Again, the
sequence of the structure of CYP102A1 was used as the
reference. Each CYPED query sequence was mapped on
the structure-based HMM profile and the resulting align-
ment was used to determine the residue corresponding
to F87.
The accuracy of this method was tested in a leave-one-
out cross-validation [44] by generating for each of the 30
crystal structures a structure-based HMM profiles, leav-
ing subsequently one structure out and mapping the
sequence of the left-out crystal structure on the corre-
sponding profile. The generated alignment was checked
for the correct prediction of the residue corresponding
to F87.
An online version of the prediction tool was inte-
grated into the CYPED homepage. Since the method
operates exclusively for sequences with CYP fold, input
sequences are first checked for applicability by sequence
homology via a BLAST [45] query using an E-value of
10
-100. Structurally conserved regions are determined as
described above.
Results
Structural Core
From the simultaneous superposition of the 31 structures
using STAMP, a multiple sequence alignment could be
derived which resulted in 257 structurally equivalent resi-
dues out of 400-450 residues. The calculated average RMS
deviation after fitting all structures by these 257 residues
was 2.4Å and their averaged sequence identity was 25%.
T h eo v e r a l lS T A M Pa l i g n m e n ts c o r eS c was 6.0 and is
above the threshold for highly similar structures. Stretches
of structurally equivalent residues (P’ij >6 . 0 )a r em a r k e d
by black boxes in the structure-based sequence alignment
(figure S1, Additional file 1). The residues of the conserved
core are organized into 19 SCRs that include at least par-
tially all defined secondary structures aA-L and b1-4. The
SCRs extracted from the structural alignment were
mapped on the reference structure CYP102A1 from Bacil-
lus megaterium (Figure 1).
A topological overview of the conserved CYP structure
illustrates the distribution of SCRs on the CYP structure
(Figure 2). Some SCRs are part of individual secondary
structures; other SCRs include several secondary struc-
ture elements. Among these, SCR3 comprises b1-2 and
aB, SCR7 b3-1 and aE. SCR11 is assembled by aIa n d
aJa n dS C R 1 3b yb1-4 and b2-1. b2-2, b1-3 and aK’
together form SCR14 and the heme-binding Cys-pocket
and aL together form SCR16. The structural alignment
further revealed that the b-5 sheet which is not present
in all CYP structures does not belong to the conserved
parts of the CYP structures [14]. The variable termini of
the secondary structure elements aF, aG, aI, b1-4,
b4-1, and the BC-loop are surrounding the heme and
house the residues defining the SRS regions 1-6.
By applying the procedure on each CYPED sequence
and mapping it on the HMM profile generated from the
STAMP alignment, the SCRs could be identified and
annotated in all sequence entries. The conserved sec-
ondary structures appear in the online version of the
CYPED either within the annotated multisequence align-
ments or on the feature page of each protein entry. Its
labelling appears in moving over the respective region.
T h er e s u l t so ft h eo n l i n ep r e d i c t i o nf o ra n yC Y P
sequence are displayed as colored and annotated regions
and as a tabular output listing each conserved secondary
structure and the corresponding start and stop position.
BC-loop
In CYP102A1, the phenylalanine at position 87 is
assumed to mediate selectivity and activity. Due to its
proximity to the heme center, this residue has a strong
evidence to be involved in substrate binding and to con-
trol substrate specificity and regioselectivity [31]. There-
fore, the identification of residues corresponding to this
position would be beneficial in the design of CYPs with
engineered properties. Since it is located in the SRS1
region of the highly variable BC-loop the identification of
this position in enzymes without structural information
is not possible merely by sequence alignment. However, a
comprehensive analysis of the BC-loops in the structures
analyzed in this work revealed that although being highly
variable (Figure 3A), the BC-loop in almost every struc-
ture of different proteins that were compared houses one
residue, which points directly towards the heme, and
remains rigid during substrate binding, which could be
shown by comparing multiple structures of the same pro-
tein (figures S2 and S3, Additional file 1). By the overall
superposition of structures of different proteins on the
structure of CYP102A1, it could be shown that this posi-
tion is located exactly at the same position, correspond-
ing to the phenylalanine in CYP102A1 (Figure 3B)
located at position 87. Table 2 lists the corresponding
residue in each structure.
To validate our structure-based method to assign
SCRs in a one-leave-out cross-validation, the position
which corresponds to F87 in CYP102A1 was predicted
for each sequence of each structure. For 23 out of 30
(80%), the predicted positions agreed with the crystal
structure, in 7 CYPs they deviated by up to 2 residues.
To further apply and to validate the procedure, the posi-
tion was predicted in eleven structures published in pro-
gress of this study. 8 correct predictions, 2 deviations by
one position, and one wrong prediction for the case of
CYP7A1 which has in the crystal structure no residue
located at this position, again confirmed an accuracy of
80%. It should be noticed that in some crystal structures
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Page 5 of 12Figure 2 SCRs of CYPs in a topological illustration. The structurally conserved regions were derived from the STAMP alignment and their
locations are marked in red. All a-helices are visualized as blue tubes, b-sheets as grey arrows and the SRS regions of CYPs are marked as yellow
circles.
Figure 3 BC-loop region (SRS1) of CYPs. (A) Comparison of the BC-loops of P450 BM-3 [PDB: 1BU7] in beige, CYP2C9 [PDB: 1OG2] in green,
CYP154C1 [PDB: 1GWI] in pink, CYP101D [PDB: 2CPP] in yellow and CYP107A1 [PDB: 1OXA] in blue. (B) BC-loop region in P450 BM-3 [PDB: 1BU7]
and the position 87 corresponding residue in all 31 structures.
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Page 6 of 12the residue numbering of the structures deviates from
the residue numbering in the sequences due to missing
residues and therefore the numbering of the protein
structure was considered. The crystal structure of
CYP231A from the thermoacidophilic Picrophilus torri-
dus was missing a part of the BC-loop [46] which made
the prediction not clearly defined.
Amino acid composition of the F87 corresponding
position
In addition to the identification of the F87 corresponding
position, a comprehensive analysis of the sequences of all
8614 CYPED protein entries was performed in respect to
the amino acid composition, by a prediction of the posi-
tion in all sequences analogous to the SCR prediction. It
could be observed that 73% of the residues predicted at
this position include aliphatic residues and phenylalanine.
The remaining 24% at this position are small polar resi-
dues and only are 3% charged residues. Phenylalanine
(22%), leucine (22%), and valine (12%) were the most fre-
quently occuring amino acids followed by isoleucine
(10%) and alanine (9%). Other amino acids appear more
rarely with frequencies less than 4% (Figure 4). A pre-
dicted gap at this position indicates that the BC-loop
region houses no residue which is located close to the
heme or the BC-loop itself winds away from the active
site as it could be observed for example in the structures
CYP8A and CYP51B1.
Analysis of reductase interaction sites
The structural regions aJ/J’ and the insertion between
the meander loop and the Cys-pocket are of particular
interest since they were previously proposed to form the
reductase interacting face of the molecules [6]. These
sites strongly vary in their length and conformation.
The structural analysis (Figure 5) reflects the differences
of aJ/J’ (further referred to as reductase interaction site
1, RIS1) (Figure 5A) and the insertion between meander
loop and Cys-pocket (further referred to as reductase
interaction site 2, RIS2) (Figure 5B) of CYPs from differ-
ent redox classes. A comparison of the human CYP2C9
and the bacterial P450cam CYP101D shows that RIS1
(aJ/J’ region) of CYP2C9 is 18 residues longer. RIS2 dif-
fers by 9 residues between CYP2C9 and CYP101D. By
counting the number of residues spanning these regions
in the STAMP alignment (figure S1, Additional file 1), it
was revealed that these regions in class II CYPs interact-
ing with CPR-type reductases are long, in class I CYPs
extremely short or not existing at all and that those
CYPs which do not require any electron transfer partner
form a subgroup of class II, in some cases with extre-
mely long loops. The aJ/J’ region differs from 21 to 22
residues for class II (long) and 3 to 5 residues for class I
CYPs (short). The length of the meander insertion dif-
fers from 11 to 17 residues for class II (long), up to 23
residues (very long) in those CYPs which do not require
a redox partner and 3 to 5 residues for class I CYPs
(short).
Table 2 Positions which correspond to F87 in P450 BM-3
and predicted position, and prediction of positions in
new structures
CYP PDB-Code Position in crystal
structure
Predicted
position
8A 2IAG - -
51B1 1E9X - V88
55A2 1CL6 V87 V87
101D 2CPP T101 I99
107A1 1OXA G91 G91
107L1 2BVJ L93 L93
108A 1CPT T103 T103
119 1IO7 L69 L69
152A1 1IZO Q85 Q85
154A1 1ODO F88 F88
154C1 1GWI L93 L93
158A1 2DKK A97 S95
158A2 1S1F G94 G94
165B3 1LFK M89 N87
165C4 1UED S98 S98
167A1 1Q5D F96 G94
175A1 1N97 L80 L80
176A1 1T2B A91 M89
199A2 2FR7 L100 L100
245A1 2Z3T V99 V99
1A2 2HI4 T124 S126
2A6 1Z10 V117 V117
2A13 2P85 A117 A117
2B4 1SUO I114 I114
2C5 1N6B A113 A113
2C8 1PQ2 I113 I113
2C9 1OG2 V113 V113
2D6 2F9Q F120 F120
2R1 2OJD L125 L125
3A4 1TQN S119 S119
102A1 1BU7
(reference)
F87 F87
2E1 3E4E I94 I94
3A43 2V0M S119 S119
7A1 2DAX - D98
19A1 3EQM F134 F134
46A1 2Q9F V126 S127
74A1 2RCH S128 L127
105A1 2ZBX I96 I96
105K1 2Z36 L96 L96
120A1 2VE3 A94 A94
231A2 2RFB I48 I48
248A 3BUJ L80 L80
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sequence for RIS1 (Figure 6A) revealed two peaks in the
RIS1 length distribution. This allowed defining two
classes. Proteins having short RIS1 with less than 10
residues spanning the aJ/J’ region make up 17.5% of all
protein entries. According to the result of the length
analysis of RIS1 of the structural alignment, they com-
prise class I CYPs. Proteins having long RIS1 with more
than 15 residues spanning the aJ/J’ region make up 81%
of all protein entries. According to the result of the
length analysis of RIS1 of the structural alignment, they
comprise class II CYPs. Only 1% of all protein entries
can not reliably be assigned by RIS1 length since their
length is in between 10 and 15 amino acids.
The analysis of the length of RIS2 in each CYPED
sequence (Figure 6B) showed a distribution in three
main areas. Therefore, three classes according to the
result of the length analysis of RIS2 in the structural
alignment were defined. Proteins having short RIS2 with
less than 7 residues spanning the meander insertion
Figure 4 Residues at F87 corresponding position. Amino acid composition of predicted F87 corresponding positions in all 8614 CYPED
proteins. Green bars correspond to the percentage of aliphatic residues and phenylalanine, grey bars to amino acids of small polar nature and
blue bars to charged amino acids. ‘-’ denotes a gap.
Figure 5 Sites interacting with potential redox partners. The CPR-type FMN/FAD from Rattus norvegicus [PDB: 3ES9] is shown in yellow, the
parts of the P450 domain of CYP2C9 from Homo sapiens [PDB: 1OG2] are shown in grey and green for CYP101D from Pseudomonas putida
[PDB: 2CPP], respectively. (A) Comparison RIS1 (aJ/J’ region) of the human CYP2C9 and P450cam CYP101D. (B) Comparison of RIS2 (meander
insertion) of the human CYP2C9 and P450cam CYP101D.
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Page 8 of 12Figure 6 Analysis of RIS length. (A) Fraction of proteins for each RIS1 (aJ/J’ region) length. (B) Fraction of proteins for each RIS2 (meander
insertion) length.
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Page 9 of 12make up 18% of all protein entries. According to the
result of the length analysis of RIS2 in the structural
alignment, they comprise class I CYPs. Proteins having
long RIS2 with between 11 and 17 residues spanning
the meander insertion make up 66% of all protein
entries. According to the result of the length analysis of
RIS2 in the structural alignment, they comprise class II
CYPs, with a subgroup of proteins having very long
RIS2 with more than 18 residues spanning the meander
insertion. 4% of all protein entries can not reliably be
assigned by RIS2 length since their length is in between
8 and 10 amino acids.
0.5% of entries with RIS1 and 0.5% of entries with RIS2
length above 35 amino acids were formally assigned to
class II, but could not be further analyzed since they
comprise biochemically not characterized proteins.
Discussion
Despite their inherently low sequence similarity, all CYPs
share a common structural fold. The well-defined sec-
ondary structure elements can be found in all determined
crystal structures, which house their active-site with the
cofactor heme deeply inside the protein [21]. The genera-
tion of a structural alignment out of 31 CYP structures
revealed structurally conserved regions which contain
most of the described secondary structure elements of
the CYP fold. It could be shown that some of the second-
ary structure elements merge together to structure mod-
ules, described as structurally conserved regions (SCR)
1-19, reflecting the modular structure of cytochrome
P450 monooxygenases. The generation of a reliable
structure-based HMM profile which was applied to every
CYPED entry assisted in consistently annotating the con-
served secondary structures in the CYPED entries. But
besides addressing the problem of predicting conserved
regions, an even more challenging issue could be solved:
the identification and classification of the variable
regions.
Since the residues that determine the substrate speci-
ficity of CYPs are assumed to lie in the variable
regions [8,22], their identification is of greatest interest
for engineering of biochemical properties. Two of the
six proposed substrate recognition sites, SRS1 and
SRS5, together with the helix I directly flank the sub-
strate binding cavity and are therefore supposed to
interact with the substrate [27]. SRS1 houses a residue,
which previously was described as essential for activity,
regio- and stereoselectivity in CYP102A1 [28-30].
Located at position 87 and pointing directly towards
the heme, a corresponding residue to this phenylala-
nine can be found in almost all CYP structures. Its
l o c a t i o ni nt h eh i g h l yv a r i a b l eB C - l o o pr e g i o nm a k e s
its determination very difficult in sequences without
structural information.
The position, which corresponds to F87 in CYP102A1
could be correctly predicted in almost 80% of all ana-
lyzed CYP structures. By surveying more recent CYP
structures, the validity of the prediction could be con-
firmed. The analysis of this position in all 8614 CYP
sequences in the CYPED revealed that the residues at
this position predominantly are of aliphatic nature or a
phenylalanine, less frequently small polar amino acids
and only very infrequently of charged nature. Since the
characteristics of the residue at this position highly
influence substrate specificity and regioselectivity, its
identification contributest ot h ed e s i g no fC Y P sw i t h
more suitable properties for biocatalytic applications.
Even though there were two reductase interaction sites
proposed to be located in aJ/aJ’ and in the insertion fol-
lowing the meander loop [6], termed RIS1 and RIS2,
these regions which are highly variable in sequence and
s t r u c t u r ew e r ed i f f i c u l tt odetermine in sequences. The
identification of the preceding and the successive SCR
solved this problem. Depending on the length for RIS1,
two classes (short and long RIS1) and three classes for
RIS2 (short, long and very long RIS2) were introduced.
From the analysis of the CYP structures in respect to
their redox partner it was assumed that class II CYPs
have long RIS1 and long RIS2, class I CYPs have short
RIS1 and short RIS 2.
The largest percentage of all CYPs has long RIS1 and
long RIS2 (53%). All CYPs with available structure which
possess these long loops clearly belong to class II, and
most of them are of human origin. The class II protein
P450 BM-3 also shows the characteristic CPR-interacting
loop length. The 12% of proteins with short RIS1 and
RIS2, respectively, are assumed to be class I proteins.
27% could not be clearly classified, either because of unu-
sual long loops (above 35 residues), or a combination of
short RIS1 with long RIS2 and vice versa. This compari-
son of reductase interaction sites allows drawing conclu-
sions on its reductase interaction.
The remaining 8% of CYPs consist of proteins with
long RIS1 and very long RIS2. Members of this unusual
group cannot easily be categorized in regards to their
reductase interaction. For example, the human prostacy-
clin synthase CYP8A1, which has endoperoxidase activ-
ity and does not require a reductase as source of
electrons, is a representative of this class of proteins
[35]. It has a long RIS1, consisting of 22 amino acids
and a very long RIS2 of 23 amino acids. However, the
crystal structure for the human cholesterol 7 alpha-
hydroxylase CYP7A1 which was recently solved also
contains very long proximal loops [47] that were cor-
rectly predicted containing 22 (RIS1) and 23 (RIS2)
amino acids. CYP7A1 was previously compared to the
structure of CYP8A1 [48], but in contrast is a typical
monooxygenase.
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Page 10 of 12The fatty acid hydroxylase CYP152A1 from Bacillus
subtilis (P450Bsb) is a hydrogen peroxide driven enzyme
[49] and therefore could be assigned to those CYPs
which do not require a redox partner. CYP152A1 has a
short RIS1 of 5 amino acid residues and a long RIS2 of
11 residues, like the CPR-type interacting class II CYPs,
which is unexpected for this kind of CYP. Indeed,
CYP152A1 and its homologous protein CYP152A2 from
Clostridium acetobutylicum (P450CLA) experimentally
showed much higher conversions in the presence of a
CPR-type reductase than in the presence of hydrogen
peroxide and the absence of a reductase [50]. The
recently solved crystal structure of the allene oxide
synthase CYP74A1 is an atypical cytochrome P450
family member and does not require a reductase [51].
However, CYP74A1 also shows similar loop lengths to
class II CYPs of RIS1 of 21 AS and RIS2 of 10 AS. Due
to an unusual nine amino acid insert in the Cys-pocket
which allows its access to the protein surface, the inter-
action with a redox partner might be disrupted [51].
Therefore, CYP74A1 cannot be compared to typical
monooxygenases with similar RIS1 and RIS2 length by
our model.
Since most CYPs require electrons from a redox part-
ner, and CYP152A1 and CYP152A2 showed higher
activities by adding a reductase, it can be assumed that
the interaction of CYPs with reductases plays a pivotal
role in the CYP mechanism. Finding the optimal redox
partner for CYPs may significantly enhance their activity
but is quite difficult. The analysis and classification
which led to the prediction of possible redox partner
interactions offers the potential of engineering enhanced
interactions.
Conclusion
In order to navigate in CYP sequences and to determine
functionally relevant residues, a procedure which allows
identifying conserved modules and functionally relevant
sites within variable regions was implemented. Regions
involved in substrate binding as well as redox partner
recognition and interaction could be determined in the
absence of structural information, based on sequence
only. The structurally annotated sequences and multise-
quence alignments are accessible on the current version
of the CYPED http://www.cyped.uni-stuttgart.de. Via a
web interface integrated in the CYPED homepage at
http://www.cyped.uni-stuttgart.de/cgi-bin/strpred/
dosecpred.pl, the structural prediction is provided for
every sequence which is similar to CYPs or presumably
shares the CYP fold. The navigation in CYP sequences
and the determination of functionally relevant sites in
turn is a great advantage in the prediction of promising
targets for the design of CYPs with improved biocataly-
tic properties.
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